Page last updated: 2024-09-05

sb 203580 and Corneal Injuries

sb 203580 has been researched along with Corneal Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koizumi, N; Nakahara, M; Nakano, S; Okumura, N1
Askar, I; Chan, D; Flanagan, JG; Guo, X; Lam, S; Livne-Bar, I; Nahirnyj, A; Sivak, JM1

Other Studies

2 other study(ies) available for sb 203580 and Corneal Injuries

ArticleYear
Effect of a p38 Mitogen-Activated Protein Kinase Inhibitor on Corneal Endothelial Cell Proliferation.
    Investigative ophthalmology & visual science, 2018, 08-01, Volume: 59, Issue:10

    Topics: Animals; Blotting, Western; Cell Proliferation; Cell- and Tissue-Based Therapy; Cells, Cultured; Corneal Injuries; Disease Models, Animal; Endothelial Cells; Endothelium, Corneal; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rabbits

2018
Pharmacologic inhibition of reactive gliosis blocks TNF-α-mediated neuronal apoptosis.
    Cell death & disease, 2016, 09-29, Volume: 7, Issue:9

    Topics: Animals; Apoptosis; Astrocytes; Corneal Injuries; Disease Models, Animal; Gliosis; Imidazoles; Intermediate Filaments; Male; Mice, Inbred C57BL; Neuroglia; p38 Mitogen-Activated Protein Kinases; Polymerization; Pyridines; Retinal Neurons; Tumor Necrosis Factor-alpha; Withanolides

2016